Texas A&M University at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Texas A&M University takes part in 2 sessions at ACT 2026 in San Antonio. Its sessions cover the promise and reality of new approach methods in toxicology, from mouse studies to cell-based models. It also covers DIM-3,5 analogs that disrupt the NR4A1 and Gas6/AXL signaling axis to slow glioblastoma, an aggressive brain cancer.

OrganizationACT 2026 Attendance
Texas A&M University
College Station, TX
tamu.edu
Universities and research institutes
Public research university in College Station, Texas, with veterinary physiology and pharmacology research on toxicology and new approach methods.
Talk
Mon Nov 16
8:00am–8:55am
From Mice to Cells: My Journey Navigating the Promise and Reality of NAMs in Toxicology (Plenary 1)
New approach methods
Poster
Mon Nov 16
5:00pm–6:30pm

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Texas A&M University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction